MARKET

LONA

LONA

LeonaBio Inc
NASDAQ
8.53
+0.18
+2.16%
Opening 09:54 06/15 EDT
OPEN
8.51
PREV CLOSE
8.35
HIGH
9.36
LOW
8.51
VOLUME
3.10K
TURNOVER
--
52 WEEK HIGH
14.21
52 WEEK LOW
2.854
MARKET CAP
80.13M
P/E (TTM)
-0.4121
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LONA last week (0608-0612)?
Weekly Report · 3h ago
Weekly Report: what happened at LONA last week (0601-0605)?
Weekly Report · 06/08 10:20
Analysts’ Top Healthcare Picks: Vera Therapeutics (VERA), Johnson & Johnson (JNJ)
TipRanks · 06/05 18:01
LeonaBio presents ATH-1105 ALS program at annual ALS Drug Development Summit
PUBT · 06/04 11:02
Weekly Report: what happened at LONA last week (0525-0529)?
Weekly Report · 06/01 10:24
LeonaBio to Present ATH-1105 ALS Trial Strategy at ALS Drug Development Summit
PUBT · 05/27 11:06
LeonaBio Price Target Announced at $20.00/Share by Piper Sandler
Dow Jones · 05/27 10:04
Piper Sandler Initiates Coverage On LeonaBio with Overweight Rating, Announces Price Target of $20
Benzinga · 05/27 09:54
More
About LONA
LeonaBio, Inc., formerly Athira Pharma, Inc., is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). The Company's lead drug candidates, lasofoxifene and ATH-1105, are novel, small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. ATH-1105 is a novel, orally available, brain-penetrant, next-generation small-molecule drug candidate designed to positively modulate the neurotrophic HGF system for potential treatment of neurodegenerative diseases, including ALS, Alzheimer's disease, and Parkinson's disease. Lasofoxifene is a novel, nonsteroidal SERM with a binding profile, designed to confer potent activity against both wild-type and mutant estrogen receptors, including the clinically significant ESR1 mutations.

Webull offers LeonaBio Inc stock information, including NASDAQ: LONA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LONA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LONA stock methods without spending real money on the virtual paper trading platform.